Multiple prior studies have corroborated a negative correlation between the S100 protein family and the prognostic outlook of pancreatic cancer, early-stage non-small cell lung cancer, and colorectal cancer [33–35]. This evidence concerns the gene S100A1 and pancreatic neoplasm.